# HALOZYME THERAPEUTICS INC (HHH) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 40637H109
Page URL: https://superinvestorclub.com/stock/HHH
Last updated: 2026-07-08T11:37:40.233Z

## Summary

As of the most recent 13F filing period, HALOZYME THERAPEUTICS INC (HHH) is held by 3 tracked superinvestors with an aggregate position value of $35.8M representing 0511429381794049 shares.

## Top institutional holders (3)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 511429 | $33.1M | 0.15% | 2026-03-31 |
| 2 | [Torray LLC](https://superinvestorclub.com/manager/3250) | Torray LLC | 38179 | $2.5M | 0.36% | 2026-03-31 |
| 3 | [Richard Pzena](https://superinvestorclub.com/manager/288) | Pzena Investment Management | 4049 | $261,687 | 0.00% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2024-03-31: 1 holders, $287,282 aggregate, 07062 shares
- 2024-06-30: 1 holders, $1.7M aggregate, 033221 shares
- 2024-09-30: 1 holders, $659,119 aggregate, 011515 shares
- 2024-12-31: 1 holders, $2.7M aggregate, 055611 shares
- 2025-03-31: 1 holders, $3.5M aggregate, 055384 shares
- 2025-06-30: 1 holders, $2.1M aggregate, 040048 shares
- 2025-09-30: 3 holders, $38.8M aggregate, 0487081381214107 shares
- 2025-12-31: 3 holders, $40.6M aggregate, 0561577381354278 shares
- 2026-03-31: 3 holders, $35.8M aggregate, 0511429381794049 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "HALOZYME THERAPEUTICS INC (HHH) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/HHH), aggregating SEC 13F, Form 4, and congressional disclosures."